KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in Net LoansChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Capital Expenditures (2016 - 2025)

Healthpeak Properties (DOC) has disclosed Capital Expenditures for 17 consecutive years, with $216.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 9.31% to $216.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $763.7 million, a 27.81% increase, with the full-year FY2025 number at $763.7 million, up 27.81% from a year prior.
  • Capital Expenditures was $216.6 million for Q4 2025 at Healthpeak Properties, down from $222.7 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $250.4 million in Q3 2022 to a low of $107.0 million in Q1 2024.
  • A 5-year average of $177.7 million and a median of $174.9 million in 2021 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: soared 68.41% in 2022, then plummeted 47.75% in 2024.
  • Healthpeak Properties' Capital Expenditures stood at $180.0 million in 2021, then surged by 35.98% to $244.8 million in 2022, then crashed by 39.26% to $148.7 million in 2023, then soared by 33.22% to $198.1 million in 2024, then grew by 9.31% to $216.6 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's Capital Expenditures are $216.6 million (Q4 2025), $222.7 million (Q3 2025), and $158.3 million (Q2 2025).